Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions

Journal of Autoimmunity

Volumn 39, Issue 4, 2012, Pages 441-450

  Almanzar, Giovanni ^a   Öllinger, Robert ^a   Leuenberger, Julianna ^a   Onestingel, Elisabeth ^a   Rantner, Barbara ^a   Zehm, Sarah ^a   Cardini, Benno ^a   van der Zee, Ruurd ^b   Grundtman, Cecilia ^a   Wick, Georg ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Atherosclerosis; Autoantibodies; Early lesions; Heat shock protein 60; Inflammation; T cell epitopes

Indexed keywords

AUTOANTIBODY; CD40 ANTIGEN; CHAPERONIN 60; EPITOPE; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD40; ATHEROSCLEROSIS; AUTOANTIBODIES; AUTOPSY; CD4-POSITIVE T-LYMPHOCYTES; CHAPERONIN 60; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-4; MALE; MIDDLE AGED; PEPTIDES; SIGNAL TRANSDUCTION; TIME FACTORS; TUNICA INTIMA;

EID: 84869888569     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.07.006     Document Type: Article

References (49)

1. Collins R.G., Velji R., Guevara N.V., Hicks M.J., Chan L., Beaudet A.L. P-selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 2000, 191:189-194.
2. Boring L., Gosling J., Cleary M., Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998, 394:894-897.
3. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998, 2:275-281.
4. Young D.B. Heat-shock proteins: immunity and autoimmunity. Curr Opin Immunol 1992, 4:396-400.
5. Schett G., Xu Q., Amberger A., Van der Zee R., Recheis H., Willeit J., et al. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest 1995, 96:2569-2577.
6. Amberger A., Maczek C., Jurgens G., Michaelis D., Schett G., Trieb K., et al. Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress Chaperones 1997, 2:94-103.
7. Pfister G., Stroh C.M., Perschinka H., Kind M., Knoflach M., Hinterdorfer P., et al. Detection of HSP60 on the membrane surface of stressed human endothelial cells by atomic force and confocal microscopy. J Cell Sci 2005, 118:1587-1594.
8. Soltys B.J., Gupta R.S. Immunoelectron microscopic localization of the 60-kDa heat shock chaperonin protein (Hsp60) in mammalian cells. Exp Cell Res 1996, 222:16-27.
9. Soltys B.J., Gupta R.S. Cell surface localization of the 60 kDa heat shock chaperonin protein (hsp60) in mammalian cells. Cell Biol Int 1997, 21:315-320.
10. Kol A., Bourcier T., Lichtman A.H., Libby P. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 1999, 103:571-577.
11. Xu Q., Schett G., Seitz C.S., Hu Y., Gupta R.S., Wick G. Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells. Circ Res 1994, 75:1078-1085.
12. Benagiano M., D'Elios M.M., Amedei A., Azzurri A., van der Zee R., Ciervo A., et al. Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. J Immunol 2005, 174:6509-6517.
13. Rossmann A., Henderson B., Heidecker B., Seiler R., Fraedrich G., Sing M., et al. T-cells from advanced atherosclerotic lesions recognize hHSP60 and have a restricted T-cell receptor repertoire. Exp Gerontol 2008, 43:229-237.
14. Xu Q., Schett G., Perschinka H., Mayr M., Egger G., Oberhollenzer F., et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 2000, 102:14-20.
15. Xu Q., Dietrich H., Steiner H.J., Gown A.M., Schoel B., Mikuz G., et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 1992, 12:789-799.
16. Xu Q., Kleindienst R., Schett G., Waitz W., Jindal S., Gupta R.S., et al. Regression of arteriosclerotic lesions induced by immunization with heat shock protein 65-containing material in normocholesterolemic, but not hypercholesterolemic, rabbits. Atherosclerosis 1996, 123:145-155.
17. George J., Shoenfeld Y., Afek A., Gilburd B., Keren P., Shaish A., et al. Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler Thromb Vasc Biol 1999, 19:505-510.
18. Wick G., Knoflach M., Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 2004, 22:361-403.
19. Apostolakis E., Parissis H., Dougenis D. Brain death and donor heart dysfunction: implications in cardiac transplantation. J Card Surg 2010, 25:98-106.
20. Stary H.C., Chandler A.B., Dinsmore R.E., Fuster V., Glagov S., Insull W., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American heart association. Circulation 1995, 92:1355-1374.
21. Xu Q., Willeit J., Marosi M., Kleindienst R., Oberhollenzer F., Kiechl S., et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 1993, 341:255-259.
22. Hochleitner B.W., Hochleitner E.O., Obrist P., Eberl T., Amberger A., Xu Q., et al. Fluid shear stress induces heat shock protein 60 expression in endothelial cells in vitro and in vivo. Arterioscler Thromb Vasc Biol 2000, 20:617-623.
23. Mach F., Schonbeck U., Sukhova G.K., Atkinson E., Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998, 394:200-203.
24. Schonbeck U., Sukhova G.K., Shimizu K., Mach F., Libby P. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc Natl Acad Sci U S A 2000, 97:7458-7463.
25. Grundtman C., Kreutmayer S.B., Almanzar G., et al. Heat shock protein 60 and immune inflammatory responses in atherosclerosis. Arterioscler Thromb Vasc Biol 2011, 31(5):960-968.
26. Knoflach M., Kiechl S., Kind M., Said M., Sief R., Gisinger M., et al. Cardiovascular risk factors and atherosclerosis in young males: ARMY study (atherosclerosis risk-factors in male youngsters). Circulation 2003, 108:1064-1069.
27. Knoflach M., Kiechl S., Penz D., Zangerle A., Schmidauer C., Rossmann A., et al. Cardiovascular risk factors and atherosclerosis in young women: atherosclerosis risk factors in female youngsters (ARFY study). Stroke 2009, 40:1063-1069.
28. Knoflach M., Kiechl S., Mayrl B., Kind M., Gaston J.S., van der Zee R., et al. T-cell reactivity against HSP60 relates to early but not advanced atherosclerosis. Atherosclerosis 2007, 195:333-338.
29. Curry A.J., Portig I., Goodall J.C., Kirkpatrick P.J., Gaston J.S. T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens. Clin Exp Immunol 2000, 121:261-269.
30. Seitz C.S., Kleindienst R., Xu Q., Wick G. Coexpression of heat-shock protein 60 and intercellular-adhesion molecule-1 is related to increased adhesion of monocytes and T cells to aortic endothelium of rats in response to endotoxin. Lab Invest 1996, 74:241-252.
31. Hsu P.L., Hsu S.M. Abundance of heat shock proteins (hsp89, hsp60, and hsp27) in malignant cells of Hodgkin's disease. Cancer Res 1998, 58:5507-5513.
32. Whitman S.C., Ravisankar P., Daugherty A. IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice. J Interferon Cytokine Res 2002, 22:661-670.
33. Elhage R., Jawien J., Rudling M., Ljunggren H.G., TAkeda K., Akira S., et al. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 2003, 59:234-240.
34. Hauer A.D., Uyttenhove C., de Vos P., Stroobant V., Renauld J.C., van Berkel T.J., et al. Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation 2005, 112:1054-1062.
35. Von Der Thusen J.H., Kuiper J., Fekkes M.L., De Vos P., Van Berkel T.J., Biessen E.A. Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/- mice. FASEB J 2001, 15:2730-2732.
36. Pinderski L.J., Fischbein M.P., Subbanagounder G., Fishbein M.C., Kubo N., Cheroutre H., et al. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ Res 2002, 90:1064-1071.
37. Sugioka K., Naruko T., Hozumi T., Nakagawa M., Kitabayashi C., Ikura Y., et al. Elevated levels of neopterin are associated with carotid plaques with complex morphology in patients with stable angina pectoris. Atherosclerosis 2010, 208:524-530.
38. Liuzzo G., Kopecky S.L., Frye R.L., O'Fallon W.M., Maseri A., Goronzy J.J., et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 1999, 100:2135-2139.
39. Methe H., Brunner S., Wiegand D., Nabauer M., Koglin J., Edelman E.R. Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. J Am Coll Cardiol 2005, 45:1939-1945.
40. Yamashita H., Shimada K., Seki E., Mokuno H., Daida H. Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris. Am J Cardiol 2003, 91:133-136.
41. Almanzar G., Schwaiger S., Jenewein B., Keller M., Herndler-Brandstetter D., Wuerzner R., et al. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol 2005, 79:3675-3683.
42. Gupta S., Knowlton A.A. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol 2007, 292:H3052-H3056.
43. Schett G., Metzler B., Kleindienst R., Amberger A., Recheis H., Xu Q., et al. Myocardial injury leads to a release of heat shock protein (hsp) 60 and a suppression of the anti-hsp65 immune response. Cardiovasc Res 1999, 42:685-695.
44. Xiao Q., Mandal K., Schett G., Mayr M., Wick G., Oberhollenzer F., et al. Association of serum-soluble heat shock protein 60 with carotid atherosclerosis: clinical significance determined in a follow-up study. Stroke 2005, 36:2571-2576.
45. Bennett M.R., Boyle J.J. Apoptosis of vascular smooth muscle cells in atherosclerosis. Atherosclerosis 1998, 138:3-9.
46. Binder R.J., Vatner R., Srivastava P. The heat-shock protein receptors: some answers and more questions. Tissue Antigens 2004, 64:442-451.
47. Pockley A.G., Muthana M., Calderwood S.K. The dual immunoregulatory roles of stress proteins. Trends Biochem Sci 2008, 33:71-79.
48. Okada T., Ayada K., Usui S., Yokota K., Cui J., Kawahara Y., et al. Antibodies against heat shock protein 60 derived from Helicobacter pylori: diagnostic implications in cardiovascular disease. J Autoimmun 2007, 29:106-115.
49. Mandal K., Foteinos G., Jahangiri M., Xu Q. Role of antiheat shock protein 60 autoantibodies in atherosclerosis. Lupus 2005, 14:742-746.